Clinical Trial Update: Portico Next Generation Approval Study [NA]

View source ↗

Summary

Clinical trial update for Abbott's Portico Next Generation Transcatheter Aortic Valve in symptomatic severe aortic stenosis; results were posted on 2024-07-01.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• Portico Next Generation Transcatheter Aortic Valve

Snippet

Sponsor: Abbott Medical Devices | Conditions: Symptomatic Severe Aortic Stenosis | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-07-01